Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Biogen ( (BIIB) ) has issued an update.
On January 13, 2025, Biogen Inc. announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. This appointment aligns with the retirement of current Chief Financial Officer Michael McDonnell, after which Robin Kramer, the current Chief Accounting Officer, will transition to the CFO role. Godbout’s extensive experience within Biogen since 2007, and his previous roles at PricewaterhouseCoopers, underline his qualifications for this new position, potentially impacting Biogen’s financial strategy and operations.
More about Biogen
Biogen Inc. operates in the biotechnology industry, focusing on discovering, developing, and delivering innovative therapies for treating neurological diseases worldwide.
YTD Price Performance: -4.63%
Average Trading Volume: 1,501,564
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.85B
Learn more about BIIB stock on TipRanks’ Stock Analysis page.
